Nachrichten zur ANI Pharmaceuticals Inc. Aktie

ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Weeks Release

ANI (ANIP) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…

Vanda Pharmaceuticals Inc. (VNDA) Q4 2025 Earnings Call Transcript

…

Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?

Here is how ANI Pharmaceuticals (ANIP) and Aveanna Healthcare (AVAH) have performed compared to their sector so far this year.…

ANIP vs. TEVA: Which Drug Stock Is the Better Buy Right Now?

ANI Pharmaceuticals rare disease growth, led by surging Cortrophin Gel sales, is outpacing Tevas slower sales momentum in this head-to-head…

Vanda Pharmaceuticals Inc. (VNDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

…

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval

WILMINGTON, Del., Jan. 14, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, today…

ANI Pharmaceuticals überzeugt mit einem starken Umsatzausblick für das Jahr 2026 — Aktie vor Ende der Konsolidierung!

Im Biotechnologie-Bereich gibt es aktuell einige spannende Aktien, die mit schönem Momentum überzeugen. Eine Aktie, die vor einer neuen Aufwärtswelle…

ANIP Up 21% in 6 Months: Is It Worth Investing in the Stock Now?

ANI Pharmaceuticals shares are up 21% in six months as strong 2025 results, repeated earnings beats and higher guidance highlight…

Ionis Pharmaceuticals Aktienanalyse: Milliardenmarkt im Blick - RBC Capital erkennt den nächsten Wachstumsschub

Bad Marienberg (www.aktiencheck.de)???????? Ionis Pharmaceuticals hebt ab: RBC Capital sieht neues Kursziel 95 USD und enormes MarktpotenzialIonis Pharmaceuticals Inc. (ISIN:…

Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year?

Here is how ANI Pharmaceuticals (ANIP) and Aveanna Healthcare (AVAH) have performed compared to their sector so far this year.…

ANIP vs. AMRX: Which Niche Drugmaker Is the Better Pick?

ANI Pharmaceuticals rare-disease momentum, led by surging Cortrophin Gel sales, sets up a stronger growth profile than its diversified rival.…

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third Quarter 2025 Financial Results and Provides Corporate Update

WILMINGTON, Del., Nov. 17, 2025 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals,” the “Company”), a…

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to…

Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?

Here is how ANI Pharmaceuticals (ANIP) and Black Diamond (BDTX) have performed compared to their sector so far this year.…

Did ANI Pharmaceuticals (ANIP) Upgraded 2025 Outlook Just Shift Its Investment Narrative?

ANI Pharmaceuticals recently raised its full-year 2025 earnings guidance, now expecting net revenue of US$854 million to US$873 million, up…

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr. Rebecca Cohen as HOPE Medical Director

MIAMI, Oct. 20, 2025 (GLOBE NEWSWIRE) -- HOPE Therapeutics™, Inc. ("HOPE"), an interventional psychiatry network owned by NRx…

Ionis Pharmaceuticals Aktie: Positive Phase-3-Daten beflügeln Analystenmeinung - Upgrade!

New York (www.aktiencheck.de) - Ionis Pharmaceuticals-Aktienanalyse von Goldman Sachs:Salveen Richter von Goldman Sachs stuft die Aktie von Ionis Pharmaceuticals Inc.…

Is Clover Health Investments (CLOV) Outperforming Other Medical Stocks This Year?

Here is how Clover Health Investments, Corp. (CLOV) and ANI Pharmaceuticals (ANIP) have performed compared to their sector so far…

Ionis Pharmaceuticals Aktie: Phase-3-Erfolg bei Alexander-Krankheit beflügelt Kursziel

London (www.aktiencheck.de) - Ionis Pharmaceuticals-Aktienanalyse von Barclays:Die Analystin Gena Wang von Barclays bestätigt für die Aktie von Ionis Pharmaceuticals Inc.…

Ionis Pharmaceuticals Aktienanalyse: Tryngolza und Dawnzera starten durch - Raymond James passt Kursziel an!

Bad Marienberg (www.aktiencheck.de)???? Ionis Pharmaceuticals begeistert Analysten: Raymond James hebt Kursziel auf 75 USD - "strong buy"Ionis Pharmaceuticals Inc. (ISIN:…

Aurinia Pharmaceuticals Inc. (AUPH) Q2 2025 Earnings Call Transcript

…

ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Q2 Release

ANI (ANIP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…

NRx Pharmaceuticals, Inc. (NRXP) Q1 2025 Earnings Call Transcript

…

Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?

Here is how ANI Pharmaceuticals (ANIP) and Agenus (AGEN) have performed compared to their sector so far this year.…

ANI Pharmaceuticals: A Short-Term Buying Opportunity

…

Buy 4 Low-Beta Stocks ANIP, LRN, MASS & CTGO as Tariff Woes Continue

It is imperative to build a portfolio of low-beta stocks in a volatile market. ANI Pharmaceuticals, Stride, 908 Devices, &…

Tariff Woes? Play Safe With 4 Low-Beta Stocks: ANIP, EXE, AVA & CTGO

It is imperative to build a portfolio of low-beta stocks in a volatile market. ANI Pharmaceuticals, Expand Energy, Avista &…

Zacks.com featured highlights include HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree

HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree are part of the Zacks Screen of the Week article.…

NRx Pharmaceuticals, Inc. (NRXP) Q4 2024 Earnings Call Transcript

…

ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label

BAUDETTE, Minn., March 14, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today…

Zacks.com featured highlights include ANI Pharmaceuticals, Dana, Pitney Bowes, Priority Technology and Kingstone

ANI Pharmaceuticals, Dana, Pitney Bowes, Priority Technology and Kingstone are part of the Zacks Screen of the Week article.…

ANI Pharmaceuticals Reports Record Fourth Quarter and Full-Year 2024 Financial Results and Raises 2025 Guidance

BAUDETTE, Minn., Feb. 28, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today…

ANI Pharmaceuticals to Present at Raymond James’ Institutional Investors and Leerink Partners Global Healthcare Conferences in March

PRINCETON, N.J., Feb. 19, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today…

Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to…

Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year?

Here is how ANI Pharmaceuticals (ANIP) and Doximity (DOCS) have performed compared to their sector so far this year.…

ANI Pharmaceuticals: More Than Just A Generics Company

…

ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference

PRINCETON, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today…

NRx Pharmaceuticals, Inc. (NRXP) Q3 2024 Earnings Call Transcript

…

ANI Pharmaceuticals, Inc. (ANIP) Q3 2024 Earnings Call Transcript

…

ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance

BAUDETTE, Minn., Nov. 08, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today…

Vanda Pharmaceuticals Inc. (VNDA) Q3 2024 Earnings Call Transcript

…

ANI Pharmaceuticals Is Acting Like It Is Being Acquired

…

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%

PRINCETON, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today…

Cycle Pharmaceuticals Stands By $488 Million Offer for Vanda

Cycle Pharmaceuticals Ltd. is still interested in acquiring Vanda Pharmaceuticals Inc. after one of Vanda’s drugs failed to receive regulatory…

ANI Pharmaceuticals: A Rare GARP Stock In An Overbought Market

…

Aresus gibt Strategie zur Erweiterung der Produktionskapazitäten für den pharmazeutischen Wirkstoff Sinecatechins bekannt

Dermago GmbH: Strausberg (ots) - Die Aresus Pharma GmbH, ein Unternehmen der DERMAGO-Gruppe, Deutschland, gibt den Abschluss einer Kooperationsvereinbarung mit…

dpa-AFX ProFeed